Barclays PLC Cellectis S.A. Transaction History

Barclays PLC

$288 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.85 - $2.53 $1,150 - $1,573	-622 Reduced 95.69%	28 $0
Q3 2022 Nov 03, 2022	BUY	$2.42 - $4.08 $1,573 - $2,652	650 New	650 $1,000
Q1 2022 May 16, 2022	SELL	$3.45 - $8.77 $8,017 - $20,381	-2,324 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.01 - $12.84 $330,524 - $529,829	-41,264 Reduced 94.67%	2,324 $19,000
Q3 2021 Nov 09, 2021	SELL	$11.94 - $16.09 $236,423 - $318,598	-19,801 Reduced 31.24%	43,588 $549,000

Q2 2021 Aug 13, 2021	BUY	$14.36 - $20.93 $576,884 - $840,820	40,173 Added 173.04%	63,389 $980,000
Q1 2021 May 13, 2021	BUY	$18.19 - $33.25 $339,934 - $621,376	18,688 Added 412.72%	23,216 $469,000
Q4 2020 Feb 11, 2021	BUY	$15.87 - $31.64 $64,162 - $127,920	4,043 Added 833.61%	4,528 $123,000
Q3 2020 Nov 12, 2020	BUY	$15.7 - $20.84 $7,614 - $10,107	485 New	485 $9,000
Q1 2020 May 13, 2020	SELL	$7.81 - $18.82 $554 - $1,336	-71 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$9.73 - $19.31 $2,821 - $5,599	-290 Reduced 80.33%	71 $1,000
Q3 2019 Nov 14, 2019	BUY	$10.15 - $16.89 $2,639 - $4,391	260 Added 257.43%	361 $4,000
Q2 2019 Aug 14, 2019	SELL	$14.6 - $20.6 $16,512 - $23,298	-1,131 Reduced 91.8%	101 $2,000
Q1 2019 May 15, 2019	BUY	$15.53 - $19.75 $17,781 - $22,613	1,145 Added 1316.09%	1,232 $23,000
Q4 2018 Feb 14, 2019	BUY	$15.58 - $28.41 $15 - $28	1 Added 1.16%	87 $1,000
Q3 2018 Nov 14, 2018	SELL	$25.99 - $30.6 $123,712 - $145,656	-4,760 Reduced 98.23%	86 $2,000
Q2 2018 Aug 14, 2018	SELL	$27.78 - $38.53 $166 - $231	-6 Reduced 0.12%	4,846 $137,000
Q1 2018 May 15, 2018	BUY	$27.78 - $35.19 $1,444 - $1,829	52 Added 1.08%	4,852 $152,000
Q4 2017 Feb 14, 2018	SELL	$23.33 - $35.01 $240,298 - $360,603	-10,300 Reduced 68.21%	4,800 $140,000
Q3 2017 Nov 14, 2017	BUY	$21.65 - $32.18 $326,915 - $485,918	15,100	15,100 $430,000

Others Institutions Holding CLLS

# of Institutions

Shares Held

9.83M

Call Options Held

Put Options Held

30.9K

Long Focus Capital Management, LLC San Juan, PR

4.49M
Shares

$8.75 Million
0.64% of portfolio
Capital International Investors Los Angeles, CA

1.85M
Shares

$3.61 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.44M
Shares

$2.8 Million
0.0% of portfolio
Baillie Gifford & CO

827K
Shares

$1.61 Million
0.0% of portfolio
Principal Financial Group Inc Des Moines, IA

425K
Shares

$827,839
0.0% of portfolio

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $88.7M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account